Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.

Chen J, OuYang H, An X, Liu S.

PLoS One. 2018 Jan 18;13(1):e0191325. doi: 10.1371/journal.pone.0191325. eCollection 2018.

2.

Malaria infected red blood cells release small regulatory RNAs through extracellular vesicles.

Babatunde KA, Mbagwu S, Hernández-Castañeda MA, Adapa SR, Walch M, Filgueira L, Falquet L, Jiang RHY, Ghiran I, Mantel PY.

Sci Rep. 2018 Jan 17;8(1):884. doi: 10.1038/s41598-018-19149-9.

3.

A comprehensive profile of circulating RNAs in human serum.

Umu SU, Langseth H, Bucher-Johannessen C, Fromm B, Keller A, Meese E, Lauritzen M, Leithaug M, Lyle R, Rounge TB.

RNA Biol. 2018 Feb 1;15(2):242-250. doi: 10.1080/15476286.2017.1403003. Epub 2017 Dec 8.

4.

Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.

Margiotta AL, Bain LJ, Rice CD.

Anat Rec (Hoboken). 2017 Nov;300(11):1981-1992. doi: 10.1002/ar.23645. Epub 2017 Jul 20.

PMID:
28710803
5.

Nucleosome Positioning and NDR Structure at RNA Polymerase III Promoters.

Helbo AS, Lay FD, Jones PA, Liang G, Grønbæk K.

Sci Rep. 2017 Feb 8;7:41947. doi: 10.1038/srep41947.

6.

RAIN: RNA-protein Association and Interaction Networks.

Junge A, Refsgaard JC, Garde C, Pan X, Santos A, Alkan F, Anthon C, von Mering C, Workman CT, Jensen LJ, Gorodkin J.

Database (Oxford). 2017 Jan 10;2017. doi: 10.1093/database/baw167. Print 2017.

7.

Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients.

Helbo AS, Treppendahl M, Aslan D, Dimopoulos K, Nandrup-Bus C, Holm MS, Andersen MK, Liang G, Kristensen LS, Grønbæk K.

Genes (Basel). 2015 Oct 14;6(4):977-90. doi: 10.3390/genes6040977.

8.

Contributions of in vitro transcription to the understanding of human RNA polymerase III transcription.

Dumay-Odelot H, Durrieu-Gaillard S, El Ayoubi L, Parrot C, Teichmann M.

Transcription. 2014;5(1):e27526. doi: 10.4161/trns.27526. Review.

9.

3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.

Fukushima H, Abe T, Sakamoto K, Tsujimoto H, Mizuarai S, Oie S.

BMC Cancer. 2014 Aug 4;14:562. doi: 10.1186/1471-2407-14-562.

10.

Genome-wide analysis of miRNA-mRNA interactions in marrow stromal cells.

Balakrishnan I, Yang X, Brown J, Ramakrishnan A, Torok-Storb B, Kabos P, Hesselberth JR, Pillai MM.

Stem Cells. 2014 Mar;32(3):662-73. doi: 10.1002/stem.1531.

11.

Structural studies of large nucleoprotein particles, vaults.

Tanaka H, Tsukihara T.

Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(8):416-33. Review.

12.

Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake.

Yang J, Srinivasan A, Sun Y, Mrazek J, Shu Z, Kickhoefer VA, Rome LH.

Integr Biol (Camb). 2013 Jan;5(1):151-8. doi: 10.1039/c2ib20119d.

13.

Recruitment of the major vault protein by InlK: a Listeria monocytogenes strategy to avoid autophagy.

Dortet L, Mostowy S, Samba-Louaka A, Gouin E, Nahori MA, Wiemer EA, Dussurget O, Cossart P.

PLoS Pathog. 2011 Aug;7(8):e1002168. doi: 10.1371/journal.ppat.1002168. Epub 2011 Aug 4. Erratum in: PLoS Pathog. 2011 Sep;7(9). doi: 10.1371/annotation/a70544fc-6d8b-4549-921a-9e86557b0ffc. Louaka, Ascel Samba [corrected to Samba-Louaka, Ascel].

14.

Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm.

Han M, Kickhoefer VA, Nemerow GR, Rome LH.

ACS Nano. 2011 Aug 23;5(8):6128-37. doi: 10.1021/nn2014613. Epub 2011 Jul 26.

15.

Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity.

Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, Kang GY, Bang JY, Park HS, Leelayuwat C, Lee YS.

RNA. 2011 Jun;17(6):1076-89. doi: 10.1261/rna.2701111. Epub 2011 Apr 25.

16.

Gene processing control loops suggested by sequencing, splicing, and RNA folding.

Jeffries CD, Perkins DO, Guan X.

BMC Bioinformatics. 2010 Dec 20;11:602. doi: 10.1186/1471-2105-11-602.

17.

Mechanism of down-regulation of RNA polymerase III-transcribed non-coding RNA genes in macrophages by Leishmania.

Rana T, Misra S, Mittal MK, Farrow AL, Wilson KT, Linton MF, Fazio S, Willis IM, Chaudhuri G.

J Biol Chem. 2011 Feb 25;286(8):6614-26. doi: 10.1074/jbc.M110.181735. Epub 2010 Dec 13.

18.

Defining the RNA polymerase III transcriptome: Genome-wide localization of the RNA polymerase III transcription machinery in human cells.

Canella D, Praz V, Reina JH, Cousin P, Hernandez N.

Genome Res. 2010 Jun;20(6):710-21. doi: 10.1101/gr.101337.109. Epub 2010 Apr 22.

19.

Selections that optimize RNA display in the yeast three-hybrid system.

Wurster SE, Maher LJ 3rd.

RNA. 2010 Feb;16(2):253-8. doi: 10.1261/rna.1880410. Epub 2009 Dec 14. Review.

20.

Targeting vault nanoparticles to specific cell surface receptors.

Kickhoefer VA, Han M, Raval-Fernandes S, Poderycki MJ, Moniz RJ, Vaccari D, Silvestry M, Stewart PL, Kelly KA, Rome LH.

ACS Nano. 2009 Jan 27;3(1):27-36. doi: 10.1021/nn800638x.

Supplemental Content

Support Center